ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.

NEXT STORY
New evidence from 2 pivotal studies reinforces clinical value of Immunoscore® In Colon Cancer
PREV STORY
Synairgen plc – Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in the illness
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines Announces Changes to its Board of Directors

Sam Chawla, of Perceptive Advisors, to resign from VBI Board of DirectorsTomer Kariv, Chairman ...

author_avatar
NASDAQ Market News

Foamix to Host Conference Call & Webcast to Discuss Topline Results From Phase 2 Study of FDX-104 in Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. ...

author_avatar
NASDAQ Market News

Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer

SAN RAMON, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News